Rapid Micro Biosystems (RPID) Total Non-Current Liabilities (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Total Non-Current Liabilities data on file, last reported at $41.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 111.97% year-over-year to $41.6 million; the trailing twelve-month figure through Mar 2026 stood at $41.6 million (up 111.97% YoY), and the FY2025 full-year result was $41.2 million, up 80.78% from the prior year.
• Total Non-Current Liabilities grew to $41.6 million in Q1 2026, from $41.2 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $41.6 million in Q1 2026 to a low of $19.6 million in Q1 2025.
• A 5-year average of $25.4 million and a median of $22.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Peak annual rise in Total Non-Current Liabilities reached 242.93% in 2022, while the deepest fall reached 51.63% in 2022.
• Tracing RPID's Total Non-Current Liabilities over 5 years: stood at $26.3 million in 2022, then retreated by 4.01% to $25.2 million in 2023, then retreated by 9.46% to $22.8 million in 2024, then jumped by 80.78% to $41.2 million in 2025, then grew by 0.91% to $41.6 million in 2026.
• Business Quant data shows RPID's Total Non-Current Liabilities at $41.6 million in Q1 2026, $41.2 million in Q4 2025, and $39.7 million in Q3 2025.